A community-resilience model: A new way in optimizing medication adherence among schizophrenic patients

Addressing medication adherence among schizophrenic patients has been a complicated process that requires multifactorial solutions. Some aspects of non-adherence were caused by sociocultural issues, financial problems, stigma, care fragmentation, and poor insight. Medication non-adherence can lead to exacerbation of symptoms, higher rates of relapse and increased use of health services. Medication and psychotherapies were known to be an effective treatment for schizophrenia, but these did not resolve the underlying causes of the illness. Involving the community support systems, in addition to medical treatment can improve adherence to treatment. At this stage, there is little available information on the topic of the community-based models for supporting medication adherence in schizophrenic patients. The objective of this study was to explore a community resilience model as a new way of optimizing medication adherence among schizophrenic patients. A systematic review was written based on 99 data sources: Science Direct, Google Scholar, Proquest Health and Medical Complete, Proquest Psychology Journals and Proquest Science Journals from 2006 to 2019. There were only 15 articles eligible to be reviewed. The essential components of the community resilience model have been shown as an effective method for supporting medication adherence in several studies. Engaging communities to support each other, coping with emotional, social and the pressures of daily life can foster greater community resilience. The underlying principles for community resilience are focused on getting stronger, helping others, being socially organized, keeping connected, learning to reflect and share ideas, being locally interdependent and reasonably profitable. These findings could potentially inform the development of the community resilience model for optimizing medication adherence among schizophrenic patients.